Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,902 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07011732RecruitingPhase 3
Testing a drug for Alzheimer's-related agitation
This study tests an experimental drug (KarXT) to see if it safely reduces agitation in people with Alzheimer's disease. It may help if you or your loved one experiences restlessness, aggression, or irritability related to Alzheimer's.
Scottsdale, ArizonaAges 55–90 - NCT07012395RecruitingPhase 2
Long-acting antibodies for moderate to severe ulcerative colitis
This study tests new long-acting antibodies, given alone or in combination, for people with moderate to severe ulcerative colitis. The goal is to see if these treatments can help reduce inflammation and improve symptoms.
Canoga Park, CaliforniaAges 18–75 - NCT07008456RecruitingPhase 2
Testing a new sugar-bead treatment for weight loss in obesity
This study tests a new treatment—small beads of sugar that release in the lower intestine—to help people with obesity and related health conditions lose weight. It compares two different doses of the beads plus a gel to a placebo (inactive treatment).
Tbilisi, K'alak'i T'bilisiAges 18–75 - NCT07010432RecruitingPhase 1
Trial of Cagrilintide for bone health in postmenopausal women
This trial tests whether cagrilintide, a medicine similar to a natural hormone called amylin, can affect bone health. It is for postmenopausal women with obesity who do not have bone disease or other conditions affecting bone metabolism.
HerlevAges 50–70 - NCT07009171RecruitingPhase 2
Testing KDS2010 for weight loss in overweight or obese adults
This study tests a new medication called KDS2010 for people who are overweight or have obesity. The goal is to see if it helps with weight loss when combined with diet and exercise.
Suwon, Gyeonggi-doAges 18 years+ - NCT07005752RecruitingPhase 4
CnU capsule for cholesterol gallstones
This trial tests if CnU capsules shrink cholesterol gallstones in people who have stones smaller than 15 millimeters. It aims to help people dissolve stones without surgery.
Ansan, Gyeonggi-doAges 19 years+ - NCT07010263RecruitingPhase 3
AK112 for limited-stage small cell lung cancer after chemoradiation
This study tests a new drug called AK112 (a bispecific antibody that blocks both PD-1 and VEGF) as a consolidation treatment to help prevent your limited-stage small cell lung cancer from coming back after you've finished chemoradiation. It's for people whose cancer has not grown following concurrent chemotherapy and radiation.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07011745RecruitingPhase 3
Study of KarXT for Alzheimer's Agitation
This study tests a new drug combination (KarXT + KarX-EC) to see if it can safely reduce agitation in people with Alzheimer's disease. It may help if you or your loved one has bothersome agitation that affects daily life.
Chandler, ArizonaAges 55–90 - NCT07013097RecruitingPhase 1
Testing PG-033 in healthy adults: a first-in-human study
This trial tests a single dose of a new medicine called PG-033 in healthy adults. It checks how the drug moves through the body and how food affects it, to find the safest starting dose for future studies.
Beijing, Beijing MunicipalityAges 18–45 - NCT07005713RecruitingPhase 1
Study of tacabrutideg for chronic spontaneous urticaria
This trial tests a new oral medication called tacabrutideg (BGB-16673) for chronic spontaneous urticaria, a condition with frequent hives and itching. It aims to see how safe it is and how well it works, possibly offering a new option for people who still have symptoms despite antihistamines.
Beijing, Beijing MunicipalityAges 18–70 - NCT07012096Enrolling by invitation
Preventing high blood pressure with counseling
This study tests whether counseling can help prevent high blood pressure in people who live in slums and are currently healthy. If you join, you may learn ways to keep your blood pressure normal.
DhakaAges 18–70 - NCT07013591RecruitingPhase 2
Nicotinamide mononucleotide for heart surgery recovery
This study tests whether taking nicotinamide mononucleotide (a dietary supplement) before and after heart surgery can help reduce complications and improve recovery. It is for people having heart bypass or valve surgery who are at higher risk of problems after surgery.
Boston, MassachusettsAges 18 years+ - NCT07013110RecruitingPhase 2
AI-guided precision therapy for active rheumatoid arthritis
This study tests a new, AI-powered treatment approach for rheumatoid arthritis. It's for people with active disease who haven't used certain biologic or targeted therapies in the last 6 months.
SingaporeAges 21 years+ - NCT07006636Recruiting
Watermelon for heart health in postmenopausal women
This study tests whether eating watermelon can improve heart health and blood pressure in postmenopausal women with slightly elevated blood pressure. It lasts about 4 weeks and involves eating watermelon as part of your usual diet.
Los Angeles, CaliforniaAges Any age - NCT07011511RecruitingPhase 1
Testing a new malaria drug in healthy volunteers
This trial tests a new malaria drug (MMV055), alone or with another drug (MMV371), to see if it is safe and how the body processes it. It is for healthy people who want to help find new malaria treatments.
NottinghamAges 18–60 - NCT06054633Recruiting
L-arginine for knee osteoarthritis pain
This study tests whether L-arginine, a natural amino acid, can help with knee pain from osteoarthritis. You might be eligible if you are 40–80 years old, have moderate osteoarthritis on X-ray, and have had knee pain for at least 3 months.
Changsha, HunanAges 40–80 - NCT06908486Recruiting
Cognitive training for pain in type 2 diabetes
This study tests a computer-based training program that may help people with type 2 diabetes and ongoing pain think about pain in a less negative way. You can do it from home on your computer over 3 months.
Camperdown, New South WalesAges 18 years+ - NCT07000357RecruitingPhase 3
Study of AZD0780 to reduce heart attack and stroke risk
This trial tests a new medication, AZD0780, to see if it helps prevent major cardiovascular events like heart attacks or strokes in people who already have heart or blood vessel disease, or are at high risk for a first event. It might be a good fit if your cholesterol isn't well-controlled despite current treatments.
Athens, AlabamaAges 18 years+ - NCT06998680Recruiting
Chinese herbs for hair loss and gray hair
This trial tests if Chinese herbal treatments can reduce hair loss and reverse gray hair over 6 months. It may help adults who have thinning hair or graying, as long as they haven't dyed or permed their hair recently.
Xiangtan, HunanAges 18–60 - NCT07002762Recruiting
Burdock root extract for high uric acid without symptoms
This trial tests whether burdock root extract can lower uric acid levels in people who have high uric acid but no symptoms of gout. It may help prevent future health problems related to high uric acid.
KyivAges 35–65 - NCT06994897RecruitingPhase 1
Safety and dosing study of PF-07985631 in healthy adults
This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.
Brussels, Bruxelles-capitale, Région deAges 18–55 - NCT06994507RecruitingPhase 3
GM1 to prevent nerve damage from breast cancer chemo
This trial tests whether a drug called GM1 can prevent nerve damage (numbness, tingling, or pain in hands/feet) caused by a common chemotherapy drug used for breast cancer. If you are starting chemotherapy with nab-paclitaxel, this study may help protect your nerves.
BeijingAges 18–75 - NCT06993233RecruitingPhase 2
Study of CIT-013 for hidradenitis suppurativa
This trial tests a new medication called CIT-013 for people with moderate to severe hidradenitis suppurativa (HS) who have not had enough relief from oral antibiotics. The goal is to see if this treatment can reduce painful bumps and abscesses.
BarrieAges 18 years+ - NCT06999720RecruitingPhase 1
Study of an experimental drug in healthy volunteers
This trial is testing a new drug called HX15001 in healthy adults to see how safe it is and how the body processes it. It may help researchers decide if the drug can be tested in people with a specific condition in the future.
Herston, QueenslandAges 18–55
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,902 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.